Stay updated on CNTO 1959 Efficacy & Safety in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the CNTO 1959 Efficacy & Safety in Psoriasis: Clinical Trial page.

Latest updates to the CNTO 1959 Efficacy & Safety in Psoriasis: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.3 is now displayed in the footer, and the previous Revision: v3.3.2 and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2 on the page. This is a backend versioning update and does not alter the displayed study information or user-facing features.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page no longer displays the government funding lapse notice related to NIH operations, affecting only an operational banner rather than the study content. No other study information appears to be changed.SummaryDifference0.3%

- Check64 days agoChange DetectedPosted study results for NCT02325219, with primary/secondary outcomes and QC dates now visible alongside the results timeline. Enrollment, completion dates, and locations have also been updated.SummaryDifference0.3%

- Check93 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference1%

- Check100 days agoChange DetectedCore content updated to v3.1.0 with removal of several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a narrowed scope; no new topics added.SummaryDifference0.1%

Stay in the know with updates to CNTO 1959 Efficacy & Safety in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CNTO 1959 Efficacy & Safety in Psoriasis: Clinical Trial page.